Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 96 | 2023 | 1930 | 10.290 |
Why?
|
Heart Valve Prosthesis | 65 | 2023 | 1479 | 8.740 |
Why?
|
Aortic Valve | 76 | 2023 | 1900 | 7.710 |
Why?
|
Angioplasty, Balloon, Coronary | 187 | 2018 | 1874 | 7.660 |
Why?
|
Heart Valve Prosthesis Implantation | 51 | 2023 | 1515 | 5.980 |
Why?
|
Stents | 198 | 2020 | 3257 | 5.960 |
Why?
|
Coronary Restenosis | 79 | 2021 | 423 | 4.760 |
Why?
|
Drug-Eluting Stents | 62 | 2021 | 753 | 4.570 |
Why?
|
Bioprosthesis | 27 | 2022 | 596 | 3.910 |
Why?
|
Coronary Angiography | 225 | 2020 | 4560 | 3.780 |
Why?
|
Prosthesis Design | 82 | 2023 | 2110 | 3.510 |
Why?
|
Coronary Disease | 163 | 2012 | 6068 | 3.210 |
Why?
|
Coronary Stenosis | 47 | 2019 | 836 | 3.100 |
Why?
|
Coronary Artery Disease | 104 | 2022 | 6416 | 2.750 |
Why?
|
Sirolimus | 48 | 2019 | 1559 | 2.740 |
Why?
|
Atherectomy, Coronary | 51 | 2019 | 148 | 2.320 |
Why?
|
Graft Occlusion, Vascular | 38 | 2016 | 551 | 2.090 |
Why?
|
Aortic Valve Insufficiency | 14 | 2023 | 576 | 2.080 |
Why?
|
Ultrasonography, Interventional | 94 | 2021 | 1480 | 1.970 |
Why?
|
Paclitaxel | 36 | 2019 | 1701 | 1.910 |
Why?
|
Cardiovascular Agents | 24 | 2020 | 845 | 1.720 |
Why?
|
Treatment Outcome | 287 | 2023 | 62693 | 1.650 |
Why?
|
Absorbable Implants | 17 | 2021 | 341 | 1.640 |
Why?
|
Coronary Vessels | 86 | 2020 | 3097 | 1.570 |
Why?
|
Angioplasty, Balloon | 23 | 2019 | 654 | 1.540 |
Why?
|
Coronary Artery Bypass | 35 | 2019 | 2272 | 1.440 |
Why?
|
Postoperative Complications | 69 | 2021 | 15194 | 1.440 |
Why?
|
Intra-Aortic Balloon Pumping | 11 | 2019 | 216 | 1.430 |
Why?
|
Cardiology | 14 | 2023 | 1654 | 1.300 |
Why?
|
Coronary Occlusion | 5 | 2019 | 303 | 1.300 |
Why?
|
Femoral Artery | 13 | 2020 | 841 | 1.230 |
Why?
|
Saphenous Vein | 28 | 2018 | 527 | 1.230 |
Why?
|
Coronary Thrombosis | 22 | 2020 | 494 | 1.180 |
Why?
|
Prosthesis Failure | 15 | 2022 | 1203 | 1.140 |
Why?
|
Aged | 329 | 2023 | 162698 | 1.110 |
Why?
|
Coated Materials, Biocompatible | 12 | 2019 | 315 | 1.090 |
Why?
|
Myocardial Revascularization | 22 | 2019 | 841 | 1.080 |
Why?
|
Aged, 80 and over | 122 | 2023 | 57650 | 1.060 |
Why?
|
Hemodynamics | 33 | 2022 | 4197 | 1.040 |
Why?
|
Time Factors | 122 | 2022 | 40050 | 1.040 |
Why?
|
Myocardial Infarction | 77 | 2022 | 11668 | 0.990 |
Why?
|
Severity of Illness Index | 56 | 2020 | 15511 | 0.910 |
Why?
|
Male | 424 | 2023 | 349022 | 0.910 |
Why?
|
Risk Factors | 138 | 2023 | 71974 | 0.900 |
Why?
|
Registries | 37 | 2022 | 8039 | 0.900 |
Why?
|
Humans | 588 | 2023 | 739398 | 0.870 |
Why?
|
Mitral Valve Insufficiency | 8 | 2019 | 1408 | 0.870 |
Why?
|
Risk Assessment | 68 | 2021 | 23294 | 0.860 |
Why?
|
Female | 414 | 2023 | 378853 | 0.860 |
Why?
|
Heart-Assist Devices | 14 | 2019 | 1191 | 0.850 |
Why?
|
Immunosuppressive Agents | 25 | 2019 | 4143 | 0.850 |
Why?
|
Popliteal Artery | 7 | 2019 | 314 | 0.820 |
Why?
|
Stroke | 27 | 2023 | 9898 | 0.810 |
Why?
|
Prospective Studies | 128 | 2023 | 53037 | 0.800 |
Why?
|
Angina, Unstable | 13 | 2010 | 926 | 0.800 |
Why?
|
Peripheral Arterial Disease | 11 | 2020 | 1169 | 0.770 |
Why?
|
Thrombectomy | 7 | 2008 | 673 | 0.760 |
Why?
|
Geriatric Assessment | 9 | 2020 | 1366 | 0.730 |
Why?
|
Blood Vessel Prosthesis Implantation | 26 | 2016 | 1381 | 0.730 |
Why?
|
Vascular Patency | 20 | 2020 | 888 | 0.730 |
Why?
|
Randomized Controlled Trials as Topic | 39 | 2020 | 9812 | 0.710 |
Why?
|
Intracranial Embolism | 4 | 2020 | 202 | 0.690 |
Why?
|
Echocardiography | 26 | 2023 | 5098 | 0.670 |
Why?
|
Follow-Up Studies | 120 | 2021 | 38942 | 0.660 |
Why?
|
Recurrence | 78 | 2019 | 8307 | 0.640 |
Why?
|
Filtration | 8 | 2010 | 235 | 0.630 |
Why?
|
Mitral Valve | 7 | 2021 | 1483 | 0.620 |
Why?
|
Heart Valve Diseases | 6 | 2019 | 1058 | 0.620 |
Why?
|
Recovery of Function | 20 | 2020 | 2924 | 0.610 |
Why?
|
Tunica Intima | 17 | 2014 | 464 | 0.610 |
Why?
|
Fibrinolytic Agents | 12 | 2008 | 2149 | 0.610 |
Why?
|
Brachytherapy | 13 | 2008 | 1247 | 0.600 |
Why?
|
Middle Aged | 301 | 2020 | 212863 | 0.600 |
Why?
|
Alloys | 5 | 2017 | 122 | 0.590 |
Why?
|
United States | 93 | 2023 | 69573 | 0.590 |
Why?
|
Platelet Aggregation Inhibitors | 27 | 2010 | 3066 | 0.580 |
Why?
|
Tissue Scaffolds | 8 | 2019 | 952 | 0.570 |
Why?
|
Bradycardia | 2 | 2008 | 305 | 0.570 |
Why?
|
Multicenter Studies as Topic | 19 | 2023 | 1583 | 0.560 |
Why?
|
Carotid Stenosis | 8 | 2015 | 851 | 0.560 |
Why?
|
Ventricular Function, Left | 13 | 2021 | 3620 | 0.550 |
Why?
|
Equipment Design | 36 | 2018 | 3583 | 0.550 |
Why?
|
Frail Elderly | 7 | 2020 | 690 | 0.520 |
Why?
|
Catheterization | 10 | 2018 | 1466 | 0.510 |
Why?
|
Aortography | 1 | 2016 | 429 | 0.500 |
Why?
|
Echocardiography, Doppler | 5 | 2018 | 934 | 0.490 |
Why?
|
Ticlopidine | 10 | 2010 | 899 | 0.490 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2006 | 641 | 0.480 |
Why?
|
Metals | 12 | 2018 | 718 | 0.480 |
Why?
|
Coronary Circulation | 23 | 2013 | 1578 | 0.480 |
Why?
|
Remote Consultation | 3 | 2010 | 239 | 0.460 |
Why?
|
Shock, Cardiogenic | 6 | 2019 | 668 | 0.460 |
Why?
|
Mortality | 8 | 2021 | 2851 | 0.440 |
Why?
|
Kaplan-Meier Estimate | 23 | 2019 | 6516 | 0.440 |
Why?
|
Angioplasty, Balloon, Laser-Assisted | 7 | 1998 | 25 | 0.430 |
Why?
|
Hospital Mortality | 16 | 2019 | 5305 | 0.430 |
Why?
|
Chromium Alloys | 5 | 2020 | 77 | 0.410 |
Why?
|
Cause of Death | 17 | 2021 | 3564 | 0.410 |
Why?
|
Congresses as Topic | 3 | 2010 | 760 | 0.400 |
Why?
|
Medicare | 13 | 2023 | 6497 | 0.400 |
Why?
|
Clinical Trials as Topic | 29 | 2020 | 7897 | 0.400 |
Why?
|
Embolism | 6 | 2010 | 408 | 0.400 |
Why?
|
Single-Blind Method | 17 | 2020 | 1585 | 0.400 |
Why?
|
Thrombosis | 20 | 2017 | 2961 | 0.390 |
Why?
|
Beta Particles | 6 | 2005 | 50 | 0.380 |
Why?
|
Tyrosine | 5 | 2008 | 1460 | 0.370 |
Why?
|
Predictive Value of Tests | 32 | 2021 | 15036 | 0.370 |
Why?
|
Intermittent Claudication | 3 | 2020 | 309 | 0.370 |
Why?
|
Somatostatin | 3 | 2005 | 460 | 0.370 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2019 | 2044 | 0.370 |
Why?
|
Angioplasty, Laser | 5 | 2001 | 21 | 0.360 |
Why?
|
Urokinase-Type Plasminogen Activator | 5 | 2002 | 337 | 0.360 |
Why?
|
Thrombolytic Therapy | 13 | 2005 | 2155 | 0.360 |
Why?
|
Constriction, Pathologic | 22 | 2019 | 1096 | 0.360 |
Why?
|
Strontium Radioisotopes | 4 | 2005 | 18 | 0.360 |
Why?
|
Endovascular Procedures | 7 | 2020 | 1947 | 0.360 |
Why?
|
Catheterization, Peripheral | 5 | 2018 | 344 | 0.360 |
Why?
|
Propensity Score | 5 | 2020 | 1749 | 0.360 |
Why?
|
Feasibility Studies | 24 | 2023 | 5058 | 0.350 |
Why?
|
Calcinosis | 13 | 2018 | 1493 | 0.350 |
Why?
|
Patient Selection | 13 | 2017 | 4211 | 0.350 |
Why?
|
Catheters | 2 | 2023 | 419 | 0.350 |
Why?
|
Stroke Volume | 10 | 2020 | 4941 | 0.340 |
Why?
|
Aorta | 3 | 2016 | 2048 | 0.340 |
Why?
|
Endpoint Determination | 9 | 2021 | 598 | 0.340 |
Why?
|
Angioplasty | 6 | 2015 | 363 | 0.340 |
Why?
|
Endarterectomy, Carotid | 6 | 2015 | 543 | 0.330 |
Why?
|
Iliac Artery | 3 | 2019 | 363 | 0.330 |
Why?
|
Yttrium Radioisotopes | 4 | 2005 | 94 | 0.330 |
Why?
|
Quality of Life | 19 | 2023 | 12640 | 0.330 |
Why?
|
Immunoglobulin Fab Fragments | 7 | 2004 | 482 | 0.320 |
Why?
|
Hyperplasia | 13 | 2014 | 1181 | 0.320 |
Why?
|
Drug Implants | 6 | 2019 | 244 | 0.320 |
Why?
|
Survival Rate | 26 | 2019 | 12761 | 0.310 |
Why?
|
Renal Artery | 3 | 2021 | 398 | 0.310 |
Why?
|
Tubulin Modulators | 3 | 2018 | 110 | 0.310 |
Why?
|
Heparin | 8 | 2004 | 1637 | 0.290 |
Why?
|
Anticoagulants | 10 | 2005 | 4582 | 0.290 |
Why?
|
Stainless Steel | 4 | 2007 | 79 | 0.290 |
Why?
|
Polyesters | 3 | 2017 | 367 | 0.290 |
Why?
|
Vibration | 1 | 2008 | 326 | 0.290 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2009 | 395 | 0.290 |
Why?
|
Biomedical Research | 2 | 2012 | 3301 | 0.290 |
Why?
|
Specialty Boards | 1 | 2008 | 227 | 0.280 |
Why?
|
Oligopeptides | 2 | 2005 | 1179 | 0.280 |
Why?
|
Organizational Objectives | 1 | 2008 | 439 | 0.280 |
Why?
|
Angina Pectoris | 13 | 2015 | 976 | 0.280 |
Why?
|
Thallium Radioisotopes | 5 | 1994 | 139 | 0.280 |
Why?
|
Incidence | 30 | 2021 | 20913 | 0.270 |
Why?
|
International Cooperation | 1 | 2012 | 1420 | 0.270 |
Why?
|
Certification | 2 | 2010 | 424 | 0.270 |
Why?
|
Length of Stay | 7 | 2019 | 6295 | 0.260 |
Why?
|
Canada | 11 | 2020 | 2021 | 0.260 |
Why?
|
Diabetic Angiopathies | 8 | 2009 | 821 | 0.250 |
Why?
|
Renal Artery Obstruction | 3 | 2021 | 248 | 0.250 |
Why?
|
Japan | 8 | 2022 | 1348 | 0.250 |
Why?
|
Fee-for-Service Plans | 1 | 2009 | 694 | 0.240 |
Why?
|
Atherectomy | 4 | 2016 | 47 | 0.240 |
Why?
|
Electrocardiography | 11 | 2021 | 6426 | 0.230 |
Why?
|
Hirudins | 1 | 2004 | 182 | 0.230 |
Why?
|
Dipyridamole | 5 | 1994 | 145 | 0.230 |
Why?
|
Equipment Failure | 6 | 2014 | 580 | 0.230 |
Why?
|
Hypertension, Renovascular | 2 | 2014 | 123 | 0.220 |
Why?
|
Societies, Medical | 4 | 2011 | 3739 | 0.220 |
Why?
|
Angiography | 8 | 2021 | 1634 | 0.220 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 2009 | 1129 | 0.210 |
Why?
|
Retrospective Studies | 37 | 2021 | 76631 | 0.210 |
Why?
|
Bundle-Branch Block | 2 | 2021 | 270 | 0.210 |
Why?
|
Logistic Models | 20 | 2020 | 13402 | 0.210 |
Why?
|
Evidence-Based Medicine | 5 | 2011 | 3606 | 0.200 |
Why?
|
Myocardial Ischemia | 6 | 2019 | 2146 | 0.200 |
Why?
|
Laboratories | 3 | 2012 | 458 | 0.200 |
Why?
|
Cardiovascular Surgical Procedures | 3 | 2018 | 194 | 0.190 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4546 | 0.190 |
Why?
|
Health Status | 5 | 2018 | 4013 | 0.190 |
Why?
|
Multivariate Analysis | 24 | 2019 | 12237 | 0.190 |
Why?
|
Reoperation | 8 | 2018 | 4192 | 0.190 |
Why?
|
Double-Blind Method | 27 | 2014 | 11985 | 0.190 |
Why?
|
France | 5 | 2020 | 516 | 0.190 |
Why?
|
Europe | 9 | 2020 | 3331 | 0.190 |
Why?
|
Polymers | 9 | 2018 | 1616 | 0.190 |
Why?
|
Cohort Studies | 25 | 2020 | 40389 | 0.180 |
Why?
|
Quality of Health Care | 4 | 2019 | 4365 | 0.180 |
Why?
|
Embolic Protection Devices | 1 | 2020 | 42 | 0.180 |
Why?
|
Chi-Square Distribution | 10 | 2017 | 3510 | 0.180 |
Why?
|
Antineoplastic Agents, Phytogenic | 4 | 2009 | 623 | 0.180 |
Why?
|
Ventricular Remodeling | 3 | 2016 | 1222 | 0.180 |
Why?
|
Denervation | 1 | 2021 | 276 | 0.180 |
Why?
|
Combined Modality Therapy | 23 | 2015 | 8605 | 0.180 |
Why?
|
Neointima | 3 | 2017 | 135 | 0.180 |
Why?
|
Activities of Daily Living | 5 | 2020 | 2410 | 0.180 |
Why?
|
Treatment Failure | 6 | 2008 | 2614 | 0.180 |
Why?
|
Chronic Disease | 11 | 2019 | 9133 | 0.180 |
Why?
|
Prosthesis Implantation | 4 | 2017 | 640 | 0.170 |
Why?
|
Blood Vessel Prosthesis | 5 | 2016 | 932 | 0.170 |
Why?
|
Catheters, Indwelling | 1 | 2002 | 422 | 0.170 |
Why?
|
Cineangiography | 10 | 2002 | 124 | 0.170 |
Why?
|
Postoperative Hemorrhage | 2 | 2020 | 410 | 0.170 |
Why?
|
Plasminogen Activators | 1 | 1999 | 209 | 0.170 |
Why?
|
Erythrocyte Transfusion | 2 | 2020 | 565 | 0.170 |
Why?
|
Risk | 6 | 2016 | 9684 | 0.170 |
Why?
|
Phosphorylcholine | 3 | 2007 | 162 | 0.160 |
Why?
|
Platelet Aggregation | 2 | 2001 | 801 | 0.160 |
Why?
|
Hypolipidemic Agents | 2 | 2000 | 606 | 0.160 |
Why?
|
Habits | 1 | 2019 | 137 | 0.160 |
Why?
|
Miniaturization | 1 | 2018 | 164 | 0.160 |
Why?
|
Heart Septum | 1 | 2019 | 313 | 0.160 |
Why?
|
Coronary Aneurysm | 6 | 2004 | 237 | 0.160 |
Why?
|
Delirium | 2 | 2020 | 1604 | 0.160 |
Why?
|
Iridium Radioisotopes | 5 | 2002 | 26 | 0.150 |
Why?
|
Bayes Theorem | 4 | 2020 | 2303 | 0.150 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2019 | 1339 | 0.150 |
Why?
|
ROC Curve | 6 | 2018 | 3526 | 0.150 |
Why?
|
Enoxaparin | 1 | 2000 | 377 | 0.150 |
Why?
|
Heart Ventricles | 3 | 2021 | 3799 | 0.150 |
Why?
|
Aspirin | 12 | 2008 | 3268 | 0.150 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2017 | 72 | 0.150 |
Why?
|
Insurance Benefits | 1 | 2018 | 182 | 0.150 |
Why?
|
Dilatation | 1 | 2018 | 286 | 0.140 |
Why?
|
Odds Ratio | 14 | 2018 | 9846 | 0.140 |
Why?
|
Ventricular Function | 2 | 2018 | 416 | 0.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2017 | 1185 | 0.140 |
Why?
|
Anesthesia, Local | 1 | 2018 | 265 | 0.140 |
Why?
|
Anti-Bacterial Agents | 4 | 2007 | 7136 | 0.140 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2018 | 143 | 0.140 |
Why?
|
Creatine Kinase, MB Form | 5 | 2009 | 214 | 0.140 |
Why?
|
Patient Care Team | 4 | 2019 | 2527 | 0.140 |
Why?
|
Endosonography | 5 | 2007 | 610 | 0.140 |
Why?
|
Cardiovascular Diseases | 12 | 2017 | 15070 | 0.140 |
Why?
|
Endocarditis | 2 | 2017 | 346 | 0.140 |
Why?
|
Chest Pain | 2 | 2003 | 1112 | 0.140 |
Why?
|
Heart Failure | 4 | 2018 | 10793 | 0.140 |
Why?
|
Endothelium, Vascular | 9 | 2007 | 4454 | 0.140 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2016 | 65 | 0.130 |
Why?
|
Tricuspid Valve | 1 | 2018 | 399 | 0.130 |
Why?
|
Rubidium Radioisotopes | 3 | 2008 | 89 | 0.130 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.130 |
Why?
|
Arteriosclerosis | 5 | 2003 | 1092 | 0.130 |
Why?
|
Recombinant Proteins | 3 | 2004 | 6610 | 0.130 |
Why?
|
Data Mining | 1 | 2020 | 536 | 0.130 |
Why?
|
Vasodilation | 4 | 2008 | 947 | 0.130 |
Why?
|
Antibodies, Monoclonal | 8 | 2004 | 9259 | 0.130 |
Why?
|
Secondary Prevention | 7 | 2003 | 1516 | 0.130 |
Why?
|
Aminophylline | 2 | 2008 | 40 | 0.130 |
Why?
|
Tantalum | 4 | 2007 | 56 | 0.130 |
Why?
|
Endarterectomy | 2 | 1992 | 195 | 0.130 |
Why?
|
Myocardial Reperfusion | 5 | 2009 | 351 | 0.120 |
Why?
|
Tomography, Optical Coherence | 5 | 2020 | 2623 | 0.120 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2018 | 345 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20055 | 0.120 |
Why?
|
Comorbidity | 11 | 2018 | 10362 | 0.120 |
Why?
|
Diabetes Complications | 8 | 2006 | 1356 | 0.120 |
Why?
|
Ischemic Attack, Transient | 1 | 2019 | 927 | 0.120 |
Why?
|
Safety | 8 | 2007 | 1186 | 0.120 |
Why?
|
Plaque, Atherosclerotic | 2 | 2016 | 1483 | 0.120 |
Why?
|
Survival Analysis | 18 | 2015 | 10247 | 0.120 |
Why?
|
Hypotension | 1 | 2019 | 881 | 0.110 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 1990 | 179 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 665 | 0.110 |
Why?
|
Nervous System Diseases | 3 | 2018 | 1621 | 0.110 |
Why?
|
Disease-Free Survival | 17 | 2010 | 6871 | 0.110 |
Why?
|
Intraoperative Complications | 7 | 2018 | 1184 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2016 | 2261 | 0.110 |
Why?
|
Databases, Factual | 8 | 2020 | 7690 | 0.110 |
Why?
|
Glomerular Filtration Rate | 2 | 2018 | 2184 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 2 | 2009 | 792 | 0.110 |
Why?
|
Creatine Kinase | 6 | 2006 | 694 | 0.110 |
Why?
|
Penile Erection | 1 | 2012 | 97 | 0.110 |
Why?
|
Retreatment | 7 | 2016 | 603 | 0.110 |
Why?
|
Ankle Brachial Index | 3 | 2020 | 154 | 0.110 |
Why?
|
Learning Curve | 1 | 2014 | 200 | 0.110 |
Why?
|
Drug Monitoring | 1 | 1998 | 961 | 0.110 |
Why?
|
Ventricular Function, Right | 1 | 2016 | 591 | 0.110 |
Why?
|
Malnutrition | 1 | 2018 | 613 | 0.100 |
Why?
|
Drug Therapy, Combination | 6 | 2012 | 6478 | 0.100 |
Why?
|
Mammary Arteries | 1 | 1992 | 70 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2005 | 3344 | 0.100 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2012 | 101 | 0.100 |
Why?
|
Ultrasonography | 22 | 2005 | 5941 | 0.100 |
Why?
|
Limb Salvage | 3 | 2019 | 433 | 0.100 |
Why?
|
Prosthesis-Related Infections | 1 | 2017 | 538 | 0.100 |
Why?
|
Device Removal | 3 | 2017 | 648 | 0.100 |
Why?
|
Blood Pressure | 9 | 2014 | 8554 | 0.100 |
Why?
|
Anesthesia, General | 1 | 2018 | 1164 | 0.100 |
Why?
|
Practice Guidelines as Topic | 5 | 2016 | 7274 | 0.100 |
Why?
|
Prognosis | 16 | 2020 | 28901 | 0.100 |
Why?
|
Cardiotonic Agents | 2 | 2008 | 535 | 0.100 |
Why?
|
Carotid Arteries | 1 | 2015 | 952 | 0.100 |
Why?
|
Adult | 61 | 2018 | 213394 | 0.100 |
Why?
|
Probability | 4 | 2007 | 2500 | 0.100 |
Why?
|
Chromium | 3 | 2018 | 123 | 0.100 |
Why?
|
Research Design | 6 | 2017 | 5959 | 0.100 |
Why?
|
Proportional Hazards Models | 9 | 2019 | 12328 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 17 | 2001 | 8977 | 0.090 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2019 | 1257 | 0.090 |
Why?
|
Reproducibility of Results | 14 | 2020 | 19811 | 0.090 |
Why?
|
Ultrasonography, Doppler | 3 | 2021 | 460 | 0.090 |
Why?
|
Growth Inhibitors | 1 | 1991 | 386 | 0.090 |
Why?
|
Biocompatible Materials | 3 | 2017 | 1730 | 0.090 |
Why?
|
Critical Care | 1 | 2003 | 2624 | 0.090 |
Why?
|
Sensitivity and Specificity | 12 | 2021 | 14740 | 0.090 |
Why?
|
Ultrasonography, Doppler, Duplex | 3 | 2016 | 205 | 0.090 |
Why?
|
Renal Insufficiency | 2 | 2010 | 803 | 0.090 |
Why?
|
Fibromuscular Dysplasia | 2 | 2001 | 58 | 0.090 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2018 | 847 | 0.090 |
Why?
|
Pilot Projects | 14 | 2020 | 8275 | 0.090 |
Why?
|
Peptides, Cyclic | 2 | 2005 | 400 | 0.090 |
Why?
|
Blood Flow Velocity | 9 | 2014 | 1437 | 0.090 |
Why?
|
Antineoplastic Agents | 5 | 2016 | 13635 | 0.090 |
Why?
|
Drug Delivery Systems | 9 | 2007 | 2220 | 0.090 |
Why?
|
Lasers, Excimer | 1 | 2009 | 72 | 0.090 |
Why?
|
Lower Extremity | 1 | 2017 | 1145 | 0.080 |
Why?
|
Hemorheology | 3 | 2007 | 145 | 0.080 |
Why?
|
Aneurysm, False | 4 | 2001 | 275 | 0.080 |
Why?
|
Heart Diseases | 3 | 2010 | 2782 | 0.080 |
Why?
|
Analysis of Variance | 10 | 2008 | 6370 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2012 | 458 | 0.080 |
Why?
|
Health Care Surveys | 2 | 2020 | 2448 | 0.080 |
Why?
|
Hyperbaric Oxygenation | 1 | 2009 | 163 | 0.080 |
Why?
|
Bluetongue virus | 1 | 2008 | 2 | 0.080 |
Why?
|
Evaluation Studies as Topic | 8 | 1997 | 1676 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2017 | 2546 | 0.080 |
Why?
|
Cardiomyopathies | 2 | 2019 | 1911 | 0.080 |
Why?
|
Endocardium | 1 | 1989 | 261 | 0.080 |
Why?
|
Heart | 7 | 2008 | 4466 | 0.080 |
Why?
|
Isoenzymes | 5 | 2004 | 1720 | 0.080 |
Why?
|
New Zealand | 4 | 2009 | 355 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2016 | 1957 | 0.080 |
Why?
|
Cobalt | 2 | 2018 | 159 | 0.080 |
Why?
|
Lung Diseases | 1 | 2017 | 1879 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1776 | 0.070 |
Why?
|
Infusions, Intravenous | 7 | 2003 | 2270 | 0.070 |
Why?
|
Observer Variation | 4 | 2015 | 2589 | 0.070 |
Why?
|
Linear Models | 10 | 2018 | 5948 | 0.070 |
Why?
|
Acute Kidney Injury | 5 | 2018 | 1941 | 0.070 |
Why?
|
Myocardium | 3 | 2009 | 4788 | 0.070 |
Why?
|
Radiography | 8 | 2015 | 6998 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2010 | 305 | 0.070 |
Why?
|
Patient Readmission | 2 | 2018 | 3106 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 1992 | 1263 | 0.070 |
Why?
|
Radiographic Image Enhancement | 2 | 1999 | 884 | 0.070 |
Why?
|
Prostheses and Implants | 3 | 2009 | 1383 | 0.070 |
Why?
|
Thromboembolism | 2 | 2007 | 984 | 0.070 |
Why?
|
Hospitals | 2 | 2019 | 3916 | 0.070 |
Why?
|
Cost-Benefit Analysis | 6 | 2018 | 5462 | 0.070 |
Why?
|
Tomography, Emission-Computed | 3 | 1994 | 1144 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3517 | 0.070 |
Why?
|
Prevalence | 6 | 2019 | 15153 | 0.070 |
Why?
|
Subclavian Artery | 2 | 2017 | 129 | 0.070 |
Why?
|
Fluoroscopy | 2 | 2008 | 915 | 0.070 |
Why?
|
Educational Technology | 1 | 2005 | 60 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3246 | 0.070 |
Why?
|
Nanoparticles | 1 | 2017 | 1906 | 0.060 |
Why?
|
Algorithms | 8 | 2016 | 13872 | 0.060 |
Why?
|
Balloon Occlusion | 1 | 2006 | 126 | 0.060 |
Why?
|
Equipment Safety | 5 | 2008 | 264 | 0.060 |
Why?
|
Ischemia | 1 | 2014 | 1908 | 0.060 |
Why?
|
Government Regulation | 1 | 2009 | 525 | 0.060 |
Why?
|
Milk | 1 | 2008 | 447 | 0.060 |
Why?
|
Necrosis | 1 | 2009 | 1643 | 0.060 |
Why?
|
Heart Function Tests | 2 | 2000 | 331 | 0.060 |
Why?
|
Thrombin | 2 | 2001 | 595 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2216 | 0.060 |
Why?
|
Systems Analysis | 1 | 2005 | 170 | 0.060 |
Why?
|
Regression Analysis | 8 | 2001 | 6452 | 0.060 |
Why?
|
Asia | 2 | 2020 | 604 | 0.060 |
Why?
|
Clinical Competence | 5 | 2012 | 4671 | 0.060 |
Why?
|
Metalloporphyrins | 1 | 2003 | 40 | 0.060 |
Why?
|
Sex Factors | 7 | 2019 | 10398 | 0.060 |
Why?
|
Vena Cava Filters | 1 | 2006 | 248 | 0.060 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 1352 | 0.060 |
Why?
|
Vasoconstriction | 2 | 2001 | 601 | 0.060 |
Why?
|
Computer Graphics | 1 | 2005 | 360 | 0.060 |
Why?
|
Atrial Fibrillation | 2 | 2019 | 5003 | 0.060 |
Why?
|
Hospitalization | 4 | 2019 | 10208 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3138 | 0.060 |
Why?
|
Career Choice | 1 | 2009 | 742 | 0.060 |
Why?
|
Hematoma | 2 | 2001 | 754 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2016 | 3514 | 0.060 |
Why?
|
Radial Artery | 1 | 2004 | 194 | 0.060 |
Why?
|
Kidney | 1 | 2018 | 7144 | 0.060 |
Why?
|
China | 2 | 2019 | 2225 | 0.050 |
Why?
|
Professional Review Organizations | 2 | 2012 | 50 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1989 | 852 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10945 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5591 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2003 | 183 | 0.050 |
Why?
|
Germany | 2 | 2019 | 853 | 0.050 |
Why?
|
Placebos | 3 | 2003 | 1678 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2008 | 3908 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4426 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2007 | 1584 | 0.050 |
Why?
|
Delayed-Action Preparations | 5 | 2004 | 962 | 0.050 |
Why?
|
South America | 1 | 2002 | 181 | 0.050 |
Why?
|
Statistics, Nonparametric | 3 | 2015 | 2881 | 0.050 |
Why?
|
Sampling Studies | 1 | 2003 | 624 | 0.050 |
Why?
|
Ethics, Research | 1 | 2003 | 190 | 0.050 |
Why?
|
Laser-Doppler Flowmetry | 2 | 1998 | 242 | 0.050 |
Why?
|
Pacemaker, Artificial | 2 | 2018 | 813 | 0.050 |
Why?
|
Disease Progression | 6 | 2006 | 13237 | 0.050 |
Why?
|
Regeneration | 1 | 2010 | 1467 | 0.050 |
Why?
|
North America | 2 | 2019 | 1249 | 0.050 |
Why?
|
Age Factors | 7 | 2020 | 18349 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1503 | 0.050 |
Why?
|
Hemorrhage | 4 | 2011 | 3441 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1628 | 0.050 |
Why?
|
Australia | 3 | 2009 | 1162 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8431 | 0.050 |
Why?
|
Vascular Diseases | 2 | 2011 | 1152 | 0.050 |
Why?
|
Total Quality Management | 2 | 2012 | 274 | 0.050 |
Why?
|
Time | 1 | 2002 | 528 | 0.050 |
Why?
|
Health Care Costs | 3 | 2009 | 3226 | 0.050 |
Why?
|
Ioxaglic Acid | 1 | 2000 | 30 | 0.050 |
Why?
|
Information Dissemination | 1 | 2009 | 1106 | 0.050 |
Why?
|
Physiology | 1 | 2001 | 113 | 0.050 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2020 | 16 | 0.050 |
Why?
|
Cytochalasin B | 1 | 2000 | 74 | 0.050 |
Why?
|
Cardiology Service, Hospital | 3 | 2005 | 246 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3863 | 0.050 |
Why?
|
Hospital Costs | 2 | 2018 | 982 | 0.050 |
Why?
|
Surface Properties | 3 | 2018 | 1181 | 0.050 |
Why?
|
Videotape Recording | 1 | 2002 | 350 | 0.050 |
Why?
|
Triiodobenzoic Acids | 1 | 2000 | 123 | 0.050 |
Why?
|
Health Care Reform | 1 | 2009 | 1258 | 0.040 |
Why?
|
Consensus | 2 | 2021 | 2913 | 0.040 |
Why?
|
Cerebrovascular Circulation | 1 | 2010 | 2757 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2001 | 270 | 0.040 |
Why?
|
Patient Discharge | 2 | 2009 | 3286 | 0.040 |
Why?
|
Contrast Media | 3 | 2010 | 5293 | 0.040 |
Why?
|
Quality Assurance, Health Care | 5 | 2012 | 2213 | 0.040 |
Why?
|
Renal Dialysis | 2 | 2018 | 1780 | 0.040 |
Why?
|
Photosensitizing Agents | 1 | 2003 | 603 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2478 | 0.040 |
Why?
|
Troponin | 1 | 2003 | 516 | 0.040 |
Why?
|
Whole Blood Coagulation Time | 1 | 1998 | 29 | 0.040 |
Why?
|
Arteries | 6 | 2003 | 1116 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9782 | 0.040 |
Why?
|
Cholesterol, LDL | 2 | 2005 | 2334 | 0.040 |
Why?
|
Observation | 2 | 2012 | 312 | 0.040 |
Why?
|
Blood Platelets | 4 | 2001 | 2506 | 0.040 |
Why?
|
Elasticity | 1 | 2000 | 656 | 0.040 |
Why?
|
Curriculum | 2 | 2010 | 3575 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 4 | 2002 | 231 | 0.040 |
Why?
|
Postoperative Period | 4 | 2016 | 1835 | 0.040 |
Why?
|
Netherlands | 3 | 2011 | 2169 | 0.040 |
Why?
|
Depression | 1 | 2018 | 7689 | 0.040 |
Why?
|
Particle Size | 1 | 2002 | 1639 | 0.040 |
Why?
|
Antithrombins | 1 | 2001 | 304 | 0.040 |
Why?
|
Antibodies, Viral | 2 | 2008 | 3151 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2711 | 0.040 |
Why?
|
Italy | 1 | 2020 | 827 | 0.040 |
Why?
|
Axillary Artery | 1 | 2017 | 49 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2000 | 441 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 546 | 0.040 |
Why?
|
Aneurysm | 1 | 2001 | 339 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 2 | 2001 | 1064 | 0.040 |
Why?
|
Oxygen | 1 | 2009 | 4158 | 0.040 |
Why?
|
Optical Fibers | 1 | 1998 | 138 | 0.040 |
Why?
|
Radiation Monitoring | 1 | 1998 | 98 | 0.040 |
Why?
|
Wounds, Penetrating | 3 | 1994 | 306 | 0.040 |
Why?
|
Hypothermia, Induced | 1 | 2002 | 746 | 0.040 |
Why?
|
Education, Medical | 1 | 2009 | 1712 | 0.040 |
Why?
|
Normal Distribution | 1 | 2018 | 282 | 0.040 |
Why?
|
Peptides | 4 | 2003 | 4395 | 0.040 |
Why?
|
Photochemotherapy | 1 | 2003 | 805 | 0.040 |
Why?
|
Pyridines | 2 | 2004 | 2810 | 0.040 |
Why?
|
Dexamethasone | 1 | 2004 | 1948 | 0.040 |
Why?
|
Animals | 15 | 2017 | 168368 | 0.040 |
Why?
|
Health Policy | 1 | 2009 | 2655 | 0.040 |
Why?
|
Preoperative Care | 3 | 2019 | 2238 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2008 | 3323 | 0.040 |
Why?
|
Nitroglycerin | 3 | 1998 | 325 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 2 | 2016 | 1689 | 0.040 |
Why?
|
Fiber Optic Technology | 1 | 1998 | 287 | 0.040 |
Why?
|
Device Approval | 1 | 2018 | 165 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2012 | 3401 | 0.030 |
Why?
|
Shock | 1 | 2018 | 318 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1376 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 423 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 2017 | 217 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2002 | 2872 | 0.030 |
Why?
|
Myocardial Contraction | 2 | 1994 | 1585 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 812 | 0.030 |
Why?
|
Benchmarking | 2 | 2012 | 1034 | 0.030 |
Why?
|
Sus scrofa | 1 | 2017 | 437 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2005 | 2275 | 0.030 |
Why?
|
Heart Rate | 7 | 2003 | 4095 | 0.030 |
Why?
|
Arteriovenous Fistula | 2 | 2001 | 316 | 0.030 |
Why?
|
Stress, Mechanical | 3 | 2007 | 1682 | 0.030 |
Why?
|
Syndrome | 1 | 2001 | 3241 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2015 | 377 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2019 | 591 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2020 | 867 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2247 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2017 | 260 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2018 | 932 | 0.030 |
Why?
|
Light | 1 | 2001 | 1380 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2009 | 2687 | 0.030 |
Why?
|
Acute Coronary Syndrome | 1 | 2008 | 2331 | 0.030 |
Why?
|
Life Tables | 2 | 2005 | 370 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2004 | 1777 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1991 | 1504 | 0.030 |
Why?
|
Taiwan | 1 | 2015 | 493 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2011 | 5702 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 1441 | 0.030 |
Why?
|
Autopsy | 1 | 2017 | 1004 | 0.030 |
Why?
|
Systole | 1 | 2016 | 956 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 538 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2007 | 1238 | 0.030 |
Why?
|
Statistics as Topic | 4 | 2004 | 2373 | 0.030 |
Why?
|
Tunica Media | 3 | 1998 | 113 | 0.030 |
Why?
|
Antihypertensive Agents | 2 | 2014 | 2039 | 0.030 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2008 | 341 | 0.030 |
Why?
|
Software | 3 | 2017 | 4423 | 0.030 |
Why?
|
Rheology | 2 | 2006 | 344 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2006 | 3109 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 1998 | 1282 | 0.030 |
Why?
|
Health Services | 1 | 2018 | 757 | 0.030 |
Why?
|
Elastic Tissue | 2 | 2005 | 65 | 0.030 |
Why?
|
Swine | 3 | 2016 | 5901 | 0.030 |
Why?
|
Health Services Research | 1 | 2020 | 1832 | 0.030 |
Why?
|
Models, Cardiovascular | 2 | 2009 | 997 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2001 | 1175 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2003 | 1191 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2009 | 2974 | 0.030 |
Why?
|
Premedication | 2 | 2004 | 257 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12948 | 0.030 |
Why?
|
Causality | 2 | 2001 | 1262 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2004 | 5076 | 0.030 |
Why?
|
Quality Indicators, Health Care | 2 | 2012 | 1828 | 0.030 |
Why?
|
Chromium Compounds | 1 | 2011 | 7 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4935 | 0.030 |
Why?
|
Creatinine | 2 | 2012 | 1903 | 0.020 |
Why?
|
Dopamine | 1 | 1999 | 1597 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2016 | 766 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2004 | 2737 | 0.020 |
Why?
|
Vasodilator Agents | 3 | 2003 | 976 | 0.020 |
Why?
|
Muscle Tonus | 1 | 1990 | 81 | 0.020 |
Why?
|
Calcium Channel Blockers | 2 | 1991 | 686 | 0.020 |
Why?
|
San Francisco | 1 | 2011 | 159 | 0.020 |
Why?
|
Brazil | 2 | 2007 | 1264 | 0.020 |
Why?
|
Platinum Compounds | 1 | 2011 | 97 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 1998 | 1170 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2014 | 630 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1997 | 1310 | 0.020 |
Why?
|
Nutritional Status | 1 | 2018 | 1587 | 0.020 |
Why?
|
Warfarin | 1 | 1998 | 1484 | 0.020 |
Why?
|
Liver Diseases | 1 | 2018 | 1244 | 0.020 |
Why?
|
Durable Medical Equipment | 1 | 2009 | 22 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1996 | 808 | 0.020 |
Why?
|
Hemostasis | 1 | 1992 | 459 | 0.020 |
Why?
|
Nitrates | 1 | 1991 | 265 | 0.020 |
Why?
|
Education, Medical, Graduate | 2 | 2012 | 2275 | 0.020 |
Why?
|
Insulin | 2 | 2009 | 6569 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2003 | 877 | 0.020 |
Why?
|
Coronary Vasospasm | 1 | 1990 | 88 | 0.020 |
Why?
|
Gamma Rays | 2 | 2002 | 321 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2009 | 177 | 0.020 |
Why?
|
Platinum | 1 | 2010 | 229 | 0.020 |
Why?
|
Social Behavior | 1 | 2015 | 1131 | 0.020 |
Why?
|
Emergencies | 2 | 1992 | 1152 | 0.020 |
Why?
|
Bluetongue | 1 | 2008 | 2 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2732 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 867 | 0.020 |
Why?
|
Cineradiography | 2 | 1998 | 24 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1525 | 0.020 |
Why?
|
Cattle Diseases | 1 | 2008 | 52 | 0.020 |
Why?
|
Muscle Development | 1 | 2010 | 271 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2007 | 3453 | 0.020 |
Why?
|
Cholesterol, HDL | 2 | 2005 | 1807 | 0.020 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1991 | 476 | 0.020 |
Why?
|
Blood Vessels | 1 | 1993 | 1126 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 1999 | 2627 | 0.020 |
Why?
|
Taxus | 1 | 2007 | 2 | 0.020 |
Why?
|
Blood Proteins | 1 | 1992 | 1122 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2008 | 11699 | 0.020 |
Why?
|
Pacific Islands | 1 | 2007 | 50 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3382 | 0.020 |
Why?
|
Singapore | 1 | 2008 | 295 | 0.020 |
Why?
|
Oxygen Consumption | 2 | 1990 | 1871 | 0.020 |
Why?
|
Calcium | 2 | 1998 | 5742 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2007 | 154 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 679 | 0.020 |
Why?
|
Calibration | 1 | 1989 | 818 | 0.020 |
Why?
|
Epoprostenol | 1 | 2007 | 252 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3854 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2009 | 21694 | 0.020 |
Why?
|
Cell Division | 3 | 1999 | 4575 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 1989 | 642 | 0.020 |
Why?
|
Capsules | 1 | 2006 | 199 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2001 | 4212 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2006 | 232 | 0.020 |
Why?
|
Body Mass Index | 2 | 2018 | 12655 | 0.020 |
Why?
|
Models, Economic | 1 | 2009 | 723 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2018 | 3672 | 0.020 |
Why?
|
Demography | 2 | 2002 | 1650 | 0.020 |
Why?
|
Models, Statistical | 1 | 2000 | 5113 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2009 | 690 | 0.020 |
Why?
|
Erythema | 1 | 1986 | 254 | 0.020 |
Why?
|
Smoking | 1 | 2001 | 8960 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1991 | 1510 | 0.020 |
Why?
|
Israel | 1 | 2007 | 794 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 1988 | 581 | 0.020 |
Why?
|
Ethics, Medical | 2 | 2001 | 793 | 0.010 |
Why?
|
Cocaine | 1 | 1989 | 1008 | 0.010 |
Why?
|
Femoral Vein | 1 | 2004 | 159 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1557 | 0.010 |
Why?
|
Health Facilities | 1 | 2009 | 564 | 0.010 |
Why?
|
Acute Disease | 3 | 2002 | 7128 | 0.010 |
Why?
|
Glucagon | 1 | 1986 | 532 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2003 | 7626 | 0.010 |
Why?
|
Program Development | 1 | 2010 | 1313 | 0.010 |
Why?
|
Blood Viscosity | 1 | 2003 | 124 | 0.010 |
Why?
|
Ethanol | 1 | 1990 | 1329 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2164 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1453 | 0.010 |
Why?
|
Rest | 1 | 2008 | 904 | 0.010 |
Why?
|
Belgium | 1 | 2002 | 103 | 0.010 |
Why?
|
Quebec | 1 | 2002 | 132 | 0.010 |
Why?
|
Nitroprusside | 1 | 2003 | 275 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 1991 | 1471 | 0.010 |
Why?
|
Verapamil | 1 | 2003 | 244 | 0.010 |
Why?
|
Thrombophilia | 1 | 2005 | 305 | 0.010 |
Why?
|
Walking | 1 | 2009 | 1177 | 0.010 |
Why?
|
Obesity | 1 | 2004 | 12643 | 0.010 |
Why?
|
Suction | 1 | 2003 | 267 | 0.010 |
Why?
|
Sodium Chloride | 2 | 1999 | 623 | 0.010 |
Why?
|
Neovascularization, Pathologic | 2 | 2002 | 2639 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3913 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2009 | 1548 | 0.010 |
Why?
|
Publishing | 1 | 2009 | 828 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16301 | 0.010 |
Why?
|
Myocarditis | 1 | 1989 | 760 | 0.010 |
Why?
|
Equipment and Supplies | 2 | 1994 | 280 | 0.010 |
Why?
|
Polysaccharides | 1 | 2008 | 1050 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1339 | 0.010 |
Why?
|
Adolescent | 4 | 2007 | 85405 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 2946 | 0.010 |
Why?
|
Child | 4 | 2012 | 77033 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 2 | 2005 | 4035 | 0.010 |
Why?
|
Massachusetts | 2 | 2005 | 8669 | 0.010 |
Why?
|
Area Under Curve | 1 | 2005 | 1655 | 0.010 |
Why?
|
Data Interpretation, Statistical | 2 | 2005 | 2716 | 0.010 |
Why?
|
Patient Care Planning | 1 | 2005 | 918 | 0.010 |
Why?
|
Costs and Cost Analysis | 2 | 1998 | 1675 | 0.010 |
Why?
|
Radiographic Magnification | 1 | 1998 | 20 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2000 | 637 | 0.010 |
Why?
|
Phantoms, Imaging | 2 | 1998 | 2504 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2280 | 0.010 |
Why?
|
Problem Solving | 1 | 2001 | 438 | 0.010 |
Why?
|
Anatomy, Cross-Sectional | 1 | 1998 | 141 | 0.010 |
Why?
|
Coronary Vessel Anomalies | 1 | 2001 | 312 | 0.010 |
Why?
|
Forecasting | 2 | 1998 | 2952 | 0.010 |
Why?
|
Body Burden | 1 | 1998 | 158 | 0.010 |
Why?
|
Pressure | 1 | 2001 | 1201 | 0.010 |
Why?
|
Professional Competence | 1 | 2001 | 448 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4768 | 0.010 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2003 | 591 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6475 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 2861 | 0.010 |
Why?
|
Hepatovirus | 1 | 1996 | 50 | 0.010 |
Why?
|
Reference Values | 2 | 1998 | 4983 | 0.010 |
Why?
|
Patient Compliance | 1 | 2007 | 2679 | 0.010 |
Why?
|
Program Evaluation | 1 | 2005 | 2484 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1990 | 943 | 0.010 |
Why?
|
Hepatitis Antibodies | 1 | 1996 | 73 | 0.010 |
Why?
|
Sex Distribution | 1 | 2001 | 2296 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2001 | 2030 | 0.010 |
Why?
|
Cnidaria | 1 | 1995 | 14 | 0.010 |
Why?
|
Quality Control | 1 | 1998 | 842 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2006 | 2140 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2006 | 3087 | 0.010 |
Why?
|
Triglycerides | 1 | 2003 | 2447 | 0.010 |
Why?
|
Random Allocation | 2 | 1991 | 2417 | 0.010 |
Why?
|
Age Distribution | 1 | 2001 | 2904 | 0.010 |
Why?
|
Arousal | 1 | 2001 | 1164 | 0.010 |
Why?
|
Exercise Test | 2 | 1994 | 2069 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 1995 | 235 | 0.010 |
Why?
|
Transducers | 1 | 1996 | 252 | 0.010 |
Why?
|
Body Weight | 1 | 2005 | 4660 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 3909 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1989 | 3497 | 0.010 |
Why?
|
Serologic Tests | 1 | 1996 | 373 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1998 | 1528 | 0.010 |
Why?
|
Biliary Tract | 1 | 1995 | 134 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1999 | 2119 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 1994 | 232 | 0.010 |
Why?
|
Compliance | 1 | 1993 | 105 | 0.010 |
Why?
|
Physical Exertion | 1 | 1997 | 695 | 0.010 |
Why?
|
Bile Ducts | 1 | 1995 | 281 | 0.010 |
Why?
|
Lasers | 1 | 1997 | 945 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1994 | 596 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3233 | 0.010 |
Why?
|
Rotation | 1 | 1994 | 523 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1996 | 719 | 0.010 |
Why?
|
Adenosine | 1 | 1997 | 819 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6361 | 0.010 |
Why?
|
Postoperative Care | 1 | 1998 | 1477 | 0.010 |
Why?
|
Cadaver | 1 | 1995 | 1330 | 0.010 |
Why?
|
Isradipine | 1 | 1990 | 14 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1992 | 516 | 0.010 |
Why?
|
Attention | 1 | 2001 | 2400 | 0.010 |
Why?
|
Anesthesia | 1 | 2001 | 1543 | 0.010 |
Why?
|
Radiation Dosage | 1 | 1998 | 1920 | 0.010 |
Why?
|
History, 20th Century | 1 | 1997 | 2742 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1989 | 174 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1996 | 1253 | 0.010 |
Why?
|
Dyspnea | 1 | 1997 | 1295 | 0.010 |
Why?
|
Heart Block | 1 | 1990 | 410 | 0.010 |
Why?
|
Research | 1 | 1997 | 2001 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1989 | 445 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1987 | 193 | 0.000 |
Why?
|
Anticholesteremic Agents | 1 | 1994 | 979 | 0.000 |
Why?
|
Cardiac Output | 1 | 1989 | 857 | 0.000 |
Why?
|
Lipids | 1 | 1998 | 3307 | 0.000 |
Why?
|
Pulmonary Circulation | 1 | 1989 | 740 | 0.000 |
Why?
|
Glucagonoma | 1 | 1986 | 14 | 0.000 |
Why?
|
Sulfhydryl Compounds | 1 | 1987 | 293 | 0.000 |
Why?
|
Acetylcysteine | 1 | 1987 | 273 | 0.000 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1991 | 717 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1987 | 376 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 35326 | 0.000 |
Why?
|
Octreotide | 1 | 1986 | 146 | 0.000 |
Why?
|
Radionuclide Imaging | 1 | 1989 | 2028 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1996 | 4522 | 0.000 |
Why?
|
Life Style | 1 | 1994 | 3817 | 0.000 |
Why?
|
Anesthetics, Local | 1 | 1989 | 987 | 0.000 |
Why?
|
Image Enhancement | 1 | 1993 | 2928 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1998 | 13880 | 0.000 |
Why?
|
Inflammation | 1 | 2000 | 10534 | 0.000 |
Why?
|
Fatty Acids | 1 | 1988 | 1804 | 0.000 |
Why?
|
Diet | 1 | 1988 | 7876 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1986 | 5213 | 0.000 |
Why?
|